Weight loss jab hospitalises 62-year-old man after it sends his metabolism 'into overdrive' - as UK experts warn of dangerous Ozempic fakes and continuing obesity drug shortages READ MORE: Urgent warning over an 'explosion' of fake Ozempic for sale By Emily Stearn, Health Reporter For Mailonline Published: 16:05, 5 August 2024 | Updated: 16:11, 5 August 2024 e-mail View comments An obese man was left in excruciating pain and forced to attend A&E after a slimming jab left him suffering an overactive thyroid. The 62-year-old, who also had type 1 diabetes , lost more than 5.6 stone (36kg) in under six months on tirzepatide — sold under the brand name Mounjaro.
But after rushing to hospital with sudden palpitations, a fever and even hand tremors, scans showed he had developed an irregular heartbeat, atrial fibrillation, dubbed a 'silent killer'. Medics also discovered he had thyrotoxicosis — a condition in which the thyroid gland, responsible for metabolism and heart rate — malfunctions, with potentially life-threatening consequences. Sharing his case in a medical journal as a warning, doctors today called for slimmers using the jabs to be monitored more closely to prevent 'adverse events'.
The 62-year-old, who also had type 1 diabetes , lost more than 5.6 stone (36kg) in under six months on tirzepatide — sold under the brand name Mounjaro. But after rushing to hospital with sudden palpitations, a fever and even hand tremors, scans showed he had developed atrial fibrillat.